These final results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the principle of targeting ACKR3 as a novel method to modulate the opioid technique, which could open new therapeutic avenues for opioid-associated disorders. Investigate on conolidine is proscribed, https://taylorg924arm9.wiki-cms.com/user